Value of Data in Oncology

High-level Conference in the context of Romanian Presidency at EU Council, organised by Centre for Innovation in Medicine.

When

5 June 2019

Where

Hotel Novotel Bucharest

InoMed

Redefining the strategies for cancer in Europe.
It’s time for a visionary data and technology - enabled EU cancer plan

The European Union has set itself the objective of reducing the incidence of cancer by 15% by 2020. Is this target really tangible?

Centre for Innovation in Medicine propose a new vision for cancer cancer in the European Union, based on data, available and emerging technologies and, last but not least, human intelligence.

Technologies

Genomics and other omics technologies pave the way for a deep understanding of cancer biology. The consequence is the incremental development of new diagnostics and therapeutic solutions for cancer patients

Data

The value of data in oncology is still unknown or underestimated due to a fragmented environment. We can improve the collection, analysis and the use of cancer data in European healthcare systems

Human intelligence

In the era of artificial intelligence, we don’t underestimate the eternal value of human minds as a key condition for a great vision and leadership in the fight against cancer across European Union

Confirmed speakers

Diana Loreta Păun

Diana Loreta
Păun

State Counselor, Public Health Department, Presidential Administration

Karim Berkouk

Karim
Berkouk

Deputy Head of Unit, DG Research & Innovation, Non Communicable Diseases and the Challenge of Healthy Ageing

Bakhuti Shengelia

Bakhuti
Shengelia

Executive Director, Global Policy and Healthcare Systems, Oncology Global Value &Access Novartis

Maurits-Jan Prinz

Maurits-Jan
Prinz

Personalised Healthcare Policy Strategy Leader, Roche

Ashley Woolmore

Ashley
Woolmore

CODE Lead Senior Vice President,

Real-World and Analytical Solutions Global Team Head of European Data and Evidence Networks CODE IQVIA

Luciana Neamtiu

Luciana
Neamtiu

Joint Research Centre, European Network of Cancer Registries

Iñaki Gutiérrez-Ibarluzea

Iñaki
Gutiérrez-Ibarluzea

Vicepresident Health Technology Assesment International

Mirko Vukcevnic

Mirko
Vukcevic

Healthcare Systems Solution Manager Oncology Region Europe Novartis

Bogi Eliasen

Bogi
Eliasen

Associate Partner Copenhagen Institute for Futures Studies

Michael Schenker

Michael
Schenker

medical oncologist at “Sf. Nectarie” Oncology Centre Craiova

Felicitas Riedl

Felicitas
Riedl

Head of Life Sciences Division, European Investment Bank

Victor Negrescu

Victor
Negrescu

former Minister of European Affairs Romania

Marian-Jean Marinescu

Marian-Jean
Marinescu

Member of European Parliament

Hans Lehrach

Hans
Lehrach

Director Max Plank Institute for Molecular Genetics Berlin

Nora Benhabiles

Nora
Benhabiles

Head of the Industrial Partnerships and External Collaborations of the Fundamental Research Division in French Atomic Energy Agency, Paris - IT Future of Cancer Treatment

Mario Sekerija

Mario
Sekerija

Head Croatian National Cancer Registry

Alexander Roediger

Alexander
Roediger

Chair of the EFPIA Oncology Platform and Executive Director Oncology Policy, Europe Middle East, Africa and Canada, MSD

David Morrison

David
Morrison

Director of Scotish Cancer Registry

Anita Burgun

Anita
Burgun

Hôpital Européen Georges Pompidou and Necker Children's Hospital

Alexander Kulesza

Alexander
Kulesza

Biomodelling and simullation Novadiscovery

Viorel Peca

Viorel
Peca

Head of Unit Future Emerging Technologies, DG Connect, European Commission

Christian Rodseth

Christian
Rodseth

President ARPIM

Marius Geantă

Marius
Geantă

President Centre for Innovation in Medicine Bucharest

Conference Schedule

08:00 - 8:45

Registration and welcome coffee

08:45 - 09:00

Welcome session

Introductory speeches from Romanian Presidency at EU Council
  • Sorina Pintea - Minister of Health Romania (TBC)
  • Diana Loreta Păun - State Counselor, Public Health Department, Presidential Administration
09:00 - 9:15

Keynote: “A new vision for cancer in EU: data, technology and human touch”

  • Marius Geantă, President Centre for Innovation in Medicine Bucharest
09:15 - 9:30

Keynote: EU cancer research: the data value in personalised medicine

  • Karim Berkouk, Deputy Head of Unit, DG Research & Innovation, Non Communicable Diseases and the Challenge of Healthy Ageing
09:30 - 9:45

Keynote: ”Unleashing the potential of data to improve cancer care”

  • Alexander Roediger, Chair of the EFPIA Oncology Platform and Executive Director Oncology Policy, Europe Middle East, Africa and Canada, MSD
09:45 - 11:00

Session 1: Capturing the real perspective on cancer in the healthcare systems across Europe

  • Bakhuti Shengelia, Executive Director, Global Policy and Healthcare Systems, Oncology Global Value &Access Novartis
  • Maurits-Jan Prinz, Personalised Healthcare Policy Strategy Leader, Roche: "Realising Personalised Healthcare through a new era of data and analytics”
  • Ashley Woolmore, CODE Lead Senior Vice President, Real-World and Analytical Solutions Global Team Head of European Data and Evidence Networks
Moderator: Marius Geantă, President Centre for Innovation in Medicine
11:00 - 11:20

Coffee break

11:20 - 12:20

Session 2: Electronic health records, cancer registries and the value of RWE in the reimbursement process

  • Luciana Neamtiu, Joint Research Centre, European Network of Cancer Registries
  • David Morrison, Director of Scotish Cancer Registry
  • Mario Sekerija, Head Croatian National Cancer Registry
  • Iñaki Gutiérrez-Ibarluzea, Vicepresident Health Technology Assesment International
Moderator: Iñaki Gutiérrez-Ibarluzea, Vicepresident Health Technology Assesment International
12:20 - 13:15

Session 3: Best practices and visionary approaches in cancer research

  • Mirko Vukcevic, Healthcare systems Solution Manager Oncology Region Europe Novartis - IMI Harmony
  • Nora Benhabiles, Head of the Industrial Partnerships and External Collaborations of the Fundamental Research Division in French Atomic Energy Agency, Paris - IT Future of Cancer Treatment
  • Alexander Kulesza - Biomodelling and simullation Novadiscovery
13:15 - 14:00

Lunch

14:00 - 14:15

Keynote: Future Proofing Healthcare - value of data

  • Bogi Eliasen, Associate Partner Copenhagen Institute for Futures Studies
14:15 - 14:30

Keynote: Financing the battle against cancer

  • Felicitas Riedl, Head of Life Sciences Division, European Investment Bank
14:30 - 14:45

Session 4: Cancer genomics: unlocking the mysteries of the disease

  • Michael Schenker: “From single molecular testing to Comprehensive Genomic Profiling in Oncology”
14:45 - 15:25

Session 5: Artificial intelligence for cancer

  • Anita Burgun, Hôpital Européen Georges Pompidou and Necker Children's Hospital
  • Karim Berkouk, Deputy Head of Unit, DG Research & Innovation Unit E4: Non Communicable Diseases and the Challenge of Healthy Ageing - EU policy in artificial intelligence
15:25 - 15:55

Keynote: Title TBA

  • Viorel Peca - Head of Unit Future Emerging Technologies, DG Connect, European Commission
15:55 - 16:15

Keynote: DigiTwins for Cancer

  • Hans Lehrach, Hans Lehrach, Director Max Plank Institute for Molecular Genetics Berlin
16:15 - 17:00

DEBATE: Medium and long-term sustainability of cancer care systems in the EU. The need for research, innovation and a new vision for cancer in the EU. What is the solution?

Panelists:
  • Hans Lehrach, Hans Lehrach, Director Max Plank Institute for Molecular Genetics Berlin
  • Viorel Peca - Head of Unit Future Emerging Technologies, DG Connect, European Commission
  • Karim Berkouk, Karim Berkouk, Deputy Head of Unit, DG Research & Innovation, Non Communicable Diseases and the Challenge of Healthy Ageing
  • Alexander Roediger, Chair of the EFPIA Oncology Platform and Executive Director Oncology Policy, Europe Middle East, Africa and Canada, MSD
  • Christian Rodseth, President ARPIM
Moderator: Nora Benhabiles, Head of the Industrial Partnerships and External Collaborations of the Fundamental Research Division in French Atomic Energy Agency, Paris
17:00 - 17:30

Next steps and conclusions: representatives from the EU Presidency Trio: Romania, Finland and Croatia

  • Cristian Grasu, Secretary of State Romanian Minister of Health
  • Victor Negrescu, former Minister of European Affairs
  • Mario Sekerija, Head Croatian National Cancer Registry
  • Representative from Finland
Moderator: Marius Geantă, President Centre for Innovation in Medicine
17:30 - 19:00

Cocktail and networking - 5 years anniversary of Centre for Innovation in Medicine

Testimonials

“We have the tools to achieve considerably more when it comes to cancer. We must continue to research and innovate, to improve treatment, care and quality of life for cancer patients and survivors. So I encourage you to engage in discussions around Horizon Europe – including on future missions and partnerships” Vytenis Andriukaitis
European Commisioner for Health and Food Safety
“Horizon Europe is designed to tackle cancer on all sides by supporting more opportunities to fund cancer research. With this, Europe can develop and deploy new technologies and techniques to change the lives of cancer patients” Carlos Moedas
European Commisioner for Research, Science and Innovation
"We agreed to work together to pool data – the raw material for AI – in sectors such as healthcare to improve cancer diagnosis and treatment” Andrus Ansip
Vice-President of European Commission

Sponsors

Platinum sponsor


Gold sponsor



Silver sponsor



Bronze sponsor


Location

Venue

Novotel Bucharest City Centre

Calea Victoriei 37B Sector 1

010061, BUCHAREST